> top > docs > PMC:3291650 > spans > 31422-31698 > annotations

PMC:3291650 / 31422-31698 JSONTXT

Annnotations TAB JSON ListView MergeView

2_test

Id Subject Object Predicate Lexical cue
22396652-21431695-98461889 272-274 21431695 denotes 83

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T13047 274-275 -RRB- denotes ]
T13046 272-274 CD denotes 83
T13045 271-272 -LRB- denotes [
T13044 262-270 NN denotes optimism
T13043 258-261 CC denotes and
T13042 250-257 NN denotes success
T13041 238-249 JJ denotes significant
T13040 226-237 VB denotes experienced
T13039 222-225 VB denotes has
T13038 220-221 -COMMA- denotes ,
T13037 215-220 NN denotes virus
T13036 205-214 NN denotes influenza
T13035 202-204 TO denotes to
T13034 194-201 VB denotes limited
T13033 190-193 RB denotes not
T13032 186-189 CC denotes but
T13031 184-185 -COMMA- denotes ,
T13030 175-184 VB denotes including
T13029 167-174 NN denotes viruses
T13028 155-166 JJ denotes respiratory
T13027 147-154 IN denotes against
T13026 141-146 NN denotes siRNA
T13025 138-140 IN denotes of
T13024 126-137 NN denotes application
T13023 115-125 JJ denotes intranasal
T13022 113-114 -COMMA- denotes ,
T13021 106-113 JJ denotes general
T13020 103-105 IN denotes in
T13019 98-102 NN denotes RNAi
T13018 95-97 IN denotes of
T13017 82-94 NN denotes applications
T13016 73-81 JJ denotes clinical
T13015 69-72 DT denotes the
T13014 66-68 IN denotes in
T13013 54-65 NN denotes bottlenecks
T13012 48-53 JJ denotes major
T13011 41-47 VB denotes remain
T13010 32-40 NN denotes delivery
T13009 25-31 NN denotes tissue
T13008 21-24 CC denotes and
T13007 9-20 NN denotes specificity
T13006 0-8 IN denotes Although
R9567 T13007 T13008 arg1Of specificity,and
R9568 T13008 T13011 arg1Of and,remain
R9569 T13010 T13008 arg2Of delivery,and
R9570 T13010 T13009 arg1Of delivery,tissue
R9571 T13011 T13006 arg2Of remain,Although
R9572 T13011 T13014 arg1Of remain,in
R9573 T13011 T13020 arg1Of remain,in
R9574 T13013 T13011 arg2Of bottlenecks,remain
R9575 T13013 T13012 arg1Of bottlenecks,major
R9576 T13017 T13014 arg2Of applications,in
R9577 T13017 T13015 arg1Of applications,the
R9578 T13017 T13016 arg1Of applications,clinical
R9579 T13017 T13018 arg1Of applications,of
R9580 T13019 T13018 arg2Of RNAi,of
R9581 T13021 T13020 arg2Of general,in
R9582 T13024 T13023 arg1Of application,intranasal
R9583 T13024 T13025 arg1Of application,of
R9584 T13024 T13027 arg1Of application,against
R9585 T13024 T13034 arg2Of application,limited
R9586 T13024 T13039 arg1Of application,has
R9587 T13024 T13040 arg1Of application,experienced
R9588 T13026 T13025 arg2Of siRNA,of
R9589 T13029 T13027 arg2Of viruses,against
R9590 T13029 T13028 arg1Of viruses,respiratory
R9591 T13029 T13030 arg1Of viruses,including
R9592 T13030 T13032 arg1Of including,but
R9593 T13032 T13031 arg1Of but,","
R9594 T13032 T13033 arg1Of but,not
R9595 T13034 T13035 arg1Of limited,to
R9596 T13037 T13035 arg2Of virus,to
R9597 T13037 T13036 arg1Of virus,influenza
R9598 T13040 T13006 arg1Of experienced,Although
R9599 T13040 T13022 arg1Of experienced,","
R9600 T13040 T13038 arg1Of experienced,","
R9601 T13040 T13039 arg2Of experienced,has
R9602 T13042 T13041 arg1Of success,significant
R9603 T13042 T13043 arg1Of success,and
R9604 T13043 T13040 arg2Of and,experienced
R9605 T13044 T13043 arg2Of optimism,and
R9606 T13044 T13045 arg1Of optimism,[
R9607 T13046 T13045 arg2Of 83,[
R9608 T13047 T13045 arg3Of ],[

UBERON-AE

Id Subject Object Predicate Lexical cue
T11702 25-31 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue

GO-BP

Id Subject Object Predicate Lexical cue
T11904 98-102 http://purl.obolibrary.org/obo/GO_0016246 denotes RNAi

sentences

Id Subject Object Predicate Lexical cue
T11737 0-276 Sentence denotes Although specificity and tissue delivery remain major bottlenecks in the clinical applications of RNAi in general, intranasal application of siRNA against respiratory viruses including, but not limited to influenza virus, has experienced significant success and optimism [83].
T191 0-276 Sentence denotes Although specificity and tissue delivery remain major bottlenecks in the clinical applications of RNAi in general, intranasal application of siRNA against respiratory viruses including, but not limited to influenza virus, has experienced significant success and optimism [83].

ICD10

Id Subject Object Predicate Lexical cue
T11907 32-40 http://purl.bioontology.org/ontology/ICD10/O80-O84.9 denotes delivery

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T14194 275-276 . denotes .
T14193 274-275 NNP denotes ]
T14192 272-274 CD denotes 83
T14191 271-272 NNP denotes [
T14190 262-270 NN denotes optimism
T14189 258-261 CC denotes and
T14188 250-257 NN denotes success
T14187 238-249 JJ denotes significant
T14186 226-237 VBN denotes experienced
T14185 222-225 VBZ denotes has
T14184 220-221 , denotes ,
T14183 215-220 NN denotes virus
T14182 205-214 VB denotes influenza
T14181 202-204 TO denotes to
T14180 194-201 VBN denotes limited
T14179 190-193 RB denotes not
T14178 186-189 CC denotes but
T14177 184-185 , denotes ,
T14176 175-184 VBG denotes including
T14175 167-174 NNS denotes viruses
T14174 155-166 JJ denotes respiratory
T14173 147-154 IN denotes against
T14172 141-146 NN denotes siRNA
T14171 138-140 IN denotes of
T14170 126-137 NN denotes application
T14169 115-125 JJ denotes intranasal
T14168 113-114 , denotes ,
T14167 106-113 JJ denotes general
T14166 103-105 IN denotes in
T14165 98-102 NNS denotes RNAi
T14164 95-97 IN denotes of
T14163 82-94 NNS denotes applications
T14162 73-81 JJ denotes clinical
T14161 69-72 DT denotes the
T14160 66-68 IN denotes in
T14159 54-65 NNS denotes bottlenecks
T14158 48-53 JJ denotes major
T14157 41-47 VBP denotes remain
T14156 32-40 NN denotes delivery
T14155 25-31 NN denotes tissue
T14154 21-24 CC denotes and
T14153 9-20 NN denotes specificity
T14152 0-8 IN denotes Although
R10718 T14152 T14157 mark Although,remain
R10719 T14153 T14157 nsubj specificity,remain
R10720 T14154 T14153 cc and,specificity
R10722 T14155 T14156 compound tissue,delivery
R10723 T14156 T14153 conj delivery,specificity
R10724 T14157 T14186 advcl remain,experienced
R10726 T14158 T14159 amod major,bottlenecks
R10727 T14159 T14157 dobj bottlenecks,remain
R10728 T14160 T14157 prep in,remain
R10730 T14161 T14163 det the,applications
R10731 T14162 T14163 amod clinical,applications
R10733 T14163 T14160 pobj applications,in
R10734 T14164 T14163 prep of,applications
R10735 T14165 T14164 pobj RNAi,of
R10736 T14166 T14165 prep in,RNAi
R10737 T14167 T14166 amod general,in
R10738 T14168 T14165 punct ",",RNAi
R10739 T14169 T14170 amod intranasal,application
R10741 T14170 T14157 npadvmod application,remain
R10742 T14171 T14170 prep of,application
R10744 T14172 T14171 pobj siRNA,of
R10746 T14173 T14172 prep against,siRNA
R10747 T14174 T14175 amod respiratory,viruses
R10748 T14175 T14173 pobj viruses,against
R10749 T14176 T14175 prep including,viruses
R10751 T14177 T14170 punct ",",application
R10752 T14178 T14170 cc but,application
R10753 T14179 T14180 neg not,limited
R10755 T14180 T14183 amod limited,virus
R10756 T14181 T14182 aux to,influenza
R10757 T14182 T14183 compound influenza,virus
R10759 T14183 T14170 conj virus,application
R10760 T14184 T14186 punct ",",experienced
R10761 T14185 T14186 aux has,experienced
R10763 T14186 T14186 ROOT experienced,experienced
R10764 T14187 T14188 amod significant,success
R10765 T14188 T14186 dobj success,experienced
R10766 T14189 T14188 cc and,success
R10768 T14190 T14188 conj optimism,success
R10769 T14191 T14193 nmod [,]
R10770 T14192 T14193 nummod 83,]
R10772 T14193 T14190 appos ],optimism
R10773 T14194 T14186 punct .,experienced